Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 21, 2023

BUY
$87.74 - $117.27 $2,544 - $3,400
29 New
29 $2,000
Q2 2022

Jul 28, 2022

SELL
$71.48 - $86.85 $4,074 - $4,950
-57 Closed
0 $0
Q1 2022

Apr 29, 2022

SELL
$74.28 - $92.69 $7,502 - $9,361
-101 Reduced 63.92%
57 $4,000
Q4 2021

Jan 19, 2022

BUY
$71.72 - $91.47 $7,674 - $9,787
107 Added 209.8%
158 $14,000
Q3 2021

Nov 01, 2021

BUY
$74.77 - $85.47 $3,813 - $4,358
51 New
51 $4,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Whittier Trust CO Of Nevada Inc Portfolio

Follow Whittier Trust CO Of Nevada Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Whittier Trust CO Of Nevada Inc, based on Form 13F filings with the SEC.

News

Stay updated on Whittier Trust CO Of Nevada Inc with notifications on news.